News

Chris Hurley Asked to Renew Three-Year Term as Americas Director of Leading Data Sciences Organization PhUSE

Chris Hurley PhUSE MMS Holdings data sciences real world evidence RWE RWD real world data pharmaceuticals biotech healthcare services consultant vendor CRO

CANTON, Mich. (November 2, 2018) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced that one of its leader’s in programming and data sciences, Chris Hurley, has been asked and has accepted a second three-year term as Americas Director of PhUSE – an independent, global organization for more than 8,000 data managers, biostatisticians, clinical programmers, and eClinical IT professionals.

As Americas Director, Chris will provide a high-level oversight for the successful delivery of all PhUSE events within North and South America, ensuring high-quality content and maintaining budgetary control. These include the region’s annual Connect and Single Day Events (SDE).

“It is incredibly rewarding to make a positive impact on the industry, within PhUSE and my own organization at MMS. Improving data standards and delving into emerging areas like the use of real world evidence in the health sector, for instance, has been gratifying and motivating at the same time,” said Chris Hurley, Associate Director, Global Data Operations, Standards, and Systems at MMS, and PhUSE Americas Director. “I have always believed in supporting your community, personally and professionally, and this allows me to give back to a career that has given me so much.”

Chris was first nominated to the position of US Events Director in 2014 and now holds the position of Americas Director to help advance PhUSE’s learning and networking opportunities for clinical data scientists across the Americas. Additionally, Chris is a member of the conference, newsletter, and single day event (SDE) committees.

“We are pleased to have Chris as a leader in this volunteer-led organization,” said Stephen Bamford, PhUSE Founder and Chairman of the Board. “Our mission at PhUSE is to provide a series of collaboration platforms for clinical data scientists globally to meet, network, and exchange ideas.”

Chris will be attending the PhUSE EU Connect 2018 conference in Frankfurt, Germany on November 4-7, 2018.

Stay up-to-date with more news at https://www.linkedin.com/company/mms-holdings-inc-/

About MMS Holdings
MMS is an award-winning, data-focused CRO that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating and was named as the Best Global Biotech CRO in the 2018 International Life Sciences Awards. For more information, visit www.mmsholdings.com or follow MMS on LinkedIn.
About PhUSE
PhUSE is an independent, not-for-profit organisation run by volunteers. Since its inception, PhUSE has expanded from its roots as a conference for European Statistical Programmers, to a global membership organisation and platform for the discussion of topics encompassing the work of data managers, biostatisticians, statistical programmers and eClinical IT professionals. For more information, visit: www.phuse.eu

Media contact
Don McLean, MBA
734-245-0165
dmclean@mmsholdings.com

###

< Back to MMS News